Bill Detail
S. 1414
Congress: 119
Title
Expedited Access to Biosimilars Act
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Sen. Rand Paul [R-KY]
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Status as of Jun 29, 1:28 PM · synced 7h ago
Introduced
2025-04-10
Data source mode: cache
Bill Engagement
Expedited Access to Biosimilars Act
Sponsor
Sen. Rand Paul [R-KY]R
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Cosponsors
0D · 1R
Partisan (R only)
LDA engagement
3 orgs · 6 filings
Top: Pharmaceutical Research and Manufactur…
Introduced
2025-04-10
Lobbyists on the case
3 orgs · 44 lobbyists · 6 filings mention S. 1414 (Expedited Access to Biosimilars Act) in LDA disclosures.
Top orgs filing
- Pharmaceutical Research and Manufacturers of America4 filings · 26 lobs
- America's Health Insurance Plans, Inc. (AHIP)1 filing · 12 lobs
- Fierce Government Relations1 filing · 6 lobs
Lobbyists on this bill
- Teresa Bill2026 Q1
- Elenora Connors2026 Q1
- Catherine Douglas2026 Q1
- Bart Forsyth2026 Q1
- Jake Freed2026 Q1Pharmaceutical Research and Manufacturers of America · Cong. Affairs Specialist - FDA; Leg. Asst., Leg. Aide/Press Asst., Staff Asst., District Field Re…
- Kelly Goldberg2026 Q1
- Judith Haron2026 Q1
- Lauren Jee2026 Q1
+ 36 more